
Ocumetics Webinar 02 04 26 - First-In-Human Study Three-Month Results Update
First-In-Human Study Three-Month Results Update Ocumetics Director and CEO, Dean Burns TSX-V:OTC | OCTQB: OTCFF | FSE: 2QB0 Learn More - https://ocumetics.com Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2




















